TMO - How to Play Intuitive Surgical Ahead of Q2 Earnings? | Benzinga
Intuitive Surgical, Inc. (NASDAQ: ISRG) will report second-quarter 2024 earnings on Jul 18. The Zacks Consensus Estimate for sales and earnings is pegged at $1.97 billion and $1.53 per share, respectively. Earnings per share estimates for ISRG have remained stable at $6.26 and $7.32 for 2024 and 2025, respectively, over the past 60 days.
Estimate Movement
Image Source: Zacks Investment Research
In the last reported quarter, ISRG delivered an earnings surprise of 8.84%. Its earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 5.83%.
Image Source: Zacks Investment Research
Earnings Whisper
Our proven model does not conclusively predict an earnings beat for ISRG Holding this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. This is not the case here.
ISRG has an Earnings ESP of 0.00% and a Zacks Rank #2 at present.
Factors to Note
The Instruments & Accessories segment is likely to report robust second-quarter results on the back of rising da Vinci procedure volume as seen in the past few quarters. However, an unfavorable currency movement is expected to have partially offset the gains from recovering demand in procedures. Meanwhile, a rise in the proportion of recurring revenues buoys well for ISRG.
Moreover, the recovery in China on the back of strong procedure growth following COVID-related setbacks in the past year is likely to have boosted sales in the soon-to-be-reported quarter.
ISRG reported sales of $1.89 billion in the first quarter, indicating growth of 11% year over year. Per management, da Vinci procedures grew ...